Healthcare
Polaris
Recorded January 07, 2026
A global, vertically integrated, biopharmaceutical company on a mission to transform the treatment of cancer
A global, vertically integrated, biopharmaceutical company on a mission to transform the treatment of cancer
Boost Fertility is on a mission to ensure clinical-grade infertility treatment is affordable and available for anyone who wants it.
Auctus Vertical Body Tethering has received a Breakthrough Device Designation and Humanitarian Device Exemption Pathway from the FDA
The Myeloma Investment Fund is part of the new wave of venture philanthropy that bridges the funding gap at early stages of drug development
Please join us in Boulder for an exclusive breakfast meeting with Nebojsa Janjic, Ph.D., CEO and President of Crestone Pharma
Vantis Vascular is developing breakthrough tools to deliver game-changing outcomes in advanced vascular intervention
AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies
AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies
Regenxbio [NASDAQ: RGNX] has three assets in pivotal trials with the potential to become standard of care in markets worth a total of $26B.
Vantis Vascular is developing breakthrough tools to deliver game-changing outcomes in advanced vascular intervention
Regenxbio [NASDAQ: RGNX] has three assets in pivotal trials with the potential to become standard of care in markets worth a total of $26B.
Developing highly targeted antibiotics that have the potential to reduce the core symptoms of Autism